Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 12:31 pm Purchase | 2023-02-09 | 13G | SpringWorks Therapeutics, Inc. SWTX | FMR LLC | 9,360,090 15.004% | 3,313,881 (+54.81%) | Filing History |
| 2023-02-09 11:32 am Purchase | 2022-12-30 | 13G | SpringWorks Therapeutics, Inc. SWTX | VANGUARD GROUP INC | 4,322,355 6.930% | 1,460,043 (+51.01%) | Filing History |
| 2023-02-07 12:59 pm Purchase | 2022-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | BlackRock Inc. BLK | 3,324,738 5.300% | 3,324,738 (New Position) | Filing History |
| 2023-01-05 4:40 pm Sale | 2023-01-03 | 13D | SpringWorks Therapeutics, Inc. SWTX | ORBIMED ADVISORS LLC | 4,985,000 8.000% | -614,842 (-10.98%) | Filing History |
| 2022-09-19 4:30 pm Purchase | 2022-09-09 | 13G | SpringWorks Therapeutics, Inc. SWTX | Boxer Capital LLC | 3,421,541 5.700% | 3,421,541 (New Position) | Filing History |
| 2022-09-19 08:27 am Purchase | 2022-09-07 | 13G | SpringWorks Therapeutics, Inc. SWTX | EcoR1 Capital, LLC | 3,460,208 5.500% | 3,460,208 (New Position) | Filing History |
| 2022-09-14 4:34 pm Sale | 2022-09-12 | 13D | SpringWorks Therapeutics, Inc. SWTX | ORBIMED ADVISORS LLC | 5,599,842 9.300% | -586,465 (-9.48%) | Filing History |
| 2022-09-13 4:30 pm Unchanged | 2022-09-09 | 13D | SpringWorks Therapeutics, Inc. SWTX | BC SW LP | 4,831,307 8.000% | 0 (Unchanged) | Filing History |
| 2022-04-11 09:01 am Purchase | 2022-04-08 | 13G | SpringWorks Therapeutics, Inc. SWTX | FMR LLC | 6,046,209 12.253% | 2,099,889 (+53.21%) | Filing History |
| 2022-02-14 9:12 pm Purchase | 2021-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | Perceptive Advisors LLC | 4,849,912 9.800% | 672,191 (+16.09%) | Filing History |
| 2022-02-11 7:01 pm Sale | 2021-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | PFIZER INC PFE | 2,340,330 4.750% | -2,242,717 (-48.94%) | Filing History |
| 2022-02-10 08:37 am Purchase | 2021-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | VANGUARD GROUP INC | 2,862,312 5.810% | 2,862,312 (New Position) | Filing History |
| 2022-02-09 10:01 am Purchase | 2022-02-08 | 13G | SpringWorks Therapeutics, Inc. SWTX | FMR LLC | 3,946,320 8.012% | 568,300 (+16.82%) | Filing History |
| 2021-08-12 5:07 pm Sale | 2021-08-10 | 13D | SpringWorks Therapeutics, Inc. SWTX | BC SW LP | 4,831,307 9.800% | -1,000,000 (-17.15%) | Filing History |
| 2021-03-11 4:30 pm Sale | 2021-03-09 | 13D | SpringWorks Therapeutics, Inc. SWTX | BC SW LP | 5,831,307 11.900% | -1,450,000 (-19.91%) | Filing History |
| 2021-03-03 6:50 pm Sale | 2021-03-01 | 13D | SpringWorks Therapeutics, Inc. SWTX | ORBIMED ADVISORS LLC | 6,186,307 12.600% | -1,220,000 (-16.47%) | Filing History |
| 2021-02-16 3:35 pm Purchase | 2020-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | Perceptive Advisors LLC | 4,177,721 8.600% | 880,199 (+26.69%) | Filing History |
| 2021-02-12 5:08 pm Sale | 2020-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | PFIZER INC PFE | 4,583,047 9.400% | -10,800 (-0.24%) | Filing History |
| 2021-02-11 5:16 pm Sale | 2020-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | BIOTECHNOLOGY VALUE FUND L P | 50 1.000% | -3,079,105 (-100.00%) | Filing History |
| 2021-02-08 10:33 am Purchase | 2021-02-05 | 13G | SpringWorks Therapeutics, Inc. SWTX | FMR LLC | 3,378,020 6.926% | 3,378,020 (New Position) | Filing History |